Tomblyn, M. B., Goldman, B. H., Thomas, C. R., Benedetti, J. K., Lenz, H., Mehta, V., . . . Blanke, C. D. (2012). CETUXIMAB PLUS CISPLATIN, IRINOTECAN, AND THORACIC RADIOTHERAPY AS DEFINITIVE TREATMENT FOR LOCALLY ADVANCED, UNRESECTABLE ESOPHAGEAL CANCER: A PHASE II STUDY OF THE SWOG (S0414).
Citação norma ChicagoTomblyn, Michael B., et al. CETUXIMAB PLUS CISPLATIN, IRINOTECAN, AND THORACIC RADIOTHERAPY AS DEFINITIVE TREATMENT FOR LOCALLY ADVANCED, UNRESECTABLE ESOPHAGEAL CANCER: A PHASE II STUDY OF THE SWOG (S0414). 2012.
Citação norma MLATomblyn, Michael B., et al. CETUXIMAB PLUS CISPLATIN, IRINOTECAN, AND THORACIC RADIOTHERAPY AS DEFINITIVE TREATMENT FOR LOCALLY ADVANCED, UNRESECTABLE ESOPHAGEAL CANCER: A PHASE II STUDY OF THE SWOG (S0414). 2012.